应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JNCE Jounce Therapeutics Inc.
退市 11-26 18:12:07 EST
1.88
+0.00
0.00%
最高
1.88
最低
1.88
成交量
0.00
今开
1.88
昨收
1.88
日振幅
0.00%
总市值
9,895万
流通市值
5,657万
总股本
5,264万
成交额
2,196万
换手率
0.00%
流通股本
3,009万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Jounce(JNCE.US)盘前暴涨30% 将与Redx达成4.25亿美元合并交易
智通财经网 · 2023-02-23
Jounce(JNCE.US)盘前暴涨30% 将与Redx达成4.25亿美元合并交易
美股异动 | Jounce Therapeutics(JNCE.US)大涨超57% 吉利德收购其免疫疗法药
金融界网站 · 2022-12-28
美股异动 | Jounce Therapeutics(JNCE.US)大涨超57% 吉利德收购其免疫疗法药
吉利德科学(GILD.US)获得癌症免疫疗法剩余权利后,Jounce(JNCE.US)股价一度飙升逾100%
智通财经 · 2022-12-28
吉利德科学(GILD.US)获得癌症免疫疗法剩余权利后,Jounce(JNCE.US)股价一度飙升逾100%
加载更多
公司概况
公司名称:
Jounce Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Jounce Therapeutics, Inc.于2012年3月根据特拉华州法律注册成立。该公司是一家临床阶段免疫治疗公司,致力于通过开发治疗方法转化癌症治疗方法,使免疫系统攻击肿瘤并提供长效给患者带来好处。
发行价格:
--
{"stockData":{"symbol":"JNCE","market":"US","secType":"STK","nameCN":"Jounce Therapeutics Inc.","latestPrice":1.88,"timestamp":1683144000000,"preClose":1.88,"halted":4,"volume":0,"delay":0,"floatShares":30088475,"shares":52635468,"eps":-0.985351,"marketStatus":"退市","marketStatusCode":4,"change":0,"latestTime":"11-26 18:12:07 EST","open":1.88,"high":1.88,"low":1.88,"amount":21960484.456712,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.985351,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"listingDate":1485493200000,"adjPreClose":1.88,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/JNCE","defaultTab":"news","newsList":[{"id":"2313985605","title":"Jounce(JNCE.US)盘前暴涨30% 将与Redx达成4.25亿美元合并交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2313985605","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2313985605?lang=zh_cn&edition=full","pubTime":"2023-02-23 18:56","pubTimestamp":1677149819,"startTime":"0","endTime":"0","summary":"英国生物技术公司Redx Pharma plc和美国Jounce Therapeutics Inc将合并,成立一家4.25亿美元的实体,专门治疗癌症和纤维化疾病。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20230223/20230223185718_88512.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230223/20230223185718_88512.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/881471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","JNCE"],"gpt_icon":0},{"id":"2294608935","title":"美股异动 | Jounce Therapeutics(JNCE.US)大涨超57% 吉利德收购其免疫疗法药","url":"https://stock-news.laohu8.com/highlight/detail?id=2294608935","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294608935?lang=zh_cn&edition=full","pubTime":"2022-12-28 22:57","pubTimestamp":1672239449,"startTime":"0","endTime":"0","summary":"格隆汇12月28日丨Jounce Therapeutics(JNCE.US)大涨超57%,报1.16美元。吉利德科学宣布将以6700万美元的价格收购该公司免疫疗法药物GS-1811(一种抗ccr8抗体)的所有知识产权和相关权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2022/12/28225737244672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","JNCE"],"gpt_icon":0},{"id":"2294671555","title":"吉利德科学(GILD.US)获得癌症免疫疗法剩余权利后,Jounce(JNCE.US)股价一度飙升逾100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2294671555","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294671555?lang=zh_cn&edition=full","pubTime":"2022-12-28 08:20","pubTimestamp":1672186857,"startTime":"0","endTime":"0","summary":"此消息公布后,Jounce在美股盘后交易中一度飙升超100%。据了解,Jounce和吉利德已于2020年签署了一份许可和开发协议。两家公司目前已经同意修改协议,吉利德现在负责进一步的研发工作,Jounce不再有资格获得任何里程碑付款或者版税。到目前为止,Jounce已经从吉利德处获得高达8500万美元的预付款,4000万美元的阶段性付款,以及3500万美元的股权投资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/853280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4568","BK4550","GILD","BK4578","LU0109394709.USD","BK4566","BK4585","BK4583","BK4139","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1585245621.USD","BK4532","LU2087621335.USD","LU0234570918.USD","JNCE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jouncetx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jounce Therapeutics, Inc.于2012年3月根据特拉华州法律注册成立。该公司是一家临床阶段免疫治疗公司,致力于通过开发治疗方法转化癌症治疗方法,使免疫系统攻击肿瘤并提供长效给患者带来好处。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.237408},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.028475},{"month":3,"riseRate":0.714286,"avgChangeRate":0.155299},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.014453},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.188342},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.097429},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.128723},{"month":8,"riseRate":0.833333,"avgChangeRate":0.116344},{"month":9,"riseRate":0.333333,"avgChangeRate":0.024692},{"month":10,"riseRate":0.5,"avgChangeRate":-0.04356},{"month":11,"riseRate":0.5,"avgChangeRate":-0.028636},{"month":12,"riseRate":0.5,"avgChangeRate":0.088637}],"exchange":"NASDAQ","name":"Jounce Therapeutics Inc.","nameEN":"Jounce Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jounce Therapeutics Inc.(JNCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jounce Therapeutics Inc.(JNCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jounce Therapeutics Inc.,JNCE,Jounce Therapeutics Inc.股票,Jounce Therapeutics Inc.股票老虎,Jounce Therapeutics Inc.股票老虎国际,Jounce Therapeutics Inc.行情,Jounce Therapeutics Inc.股票行情,Jounce Therapeutics Inc.股价,Jounce Therapeutics Inc.股市,Jounce Therapeutics Inc.股票价格,Jounce Therapeutics Inc.股票交易,Jounce Therapeutics Inc.股票购买,Jounce Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jounce Therapeutics Inc.(JNCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jounce Therapeutics Inc.(JNCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}